Global Cellulite Treatment Market

Cellulite Treatment Comprehensive Study by Treatment (Energy-based Treatment (Mechanical Suction, Mechanical Suction, and Thermal, Radiofrequency, Ultrasound, Cryolipolysis), Non-Energy-based Treatment (Topical Creams, Oral Treatment)), End user (Hospitals, Cosmetic Surgery Centers, Dermatology Clinics), Technique (Noninvasive, Minimally Invasive) Players and Region - Global Market Outlook to 2026

Cellulite Treatment Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 10.3%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
The human body has a network of connective tissue strands, termed septae, to hold fat in place. If the septae is not strong and tightly woven, fat can bulge out, giving it a dimpled and lumpy appearance. This condition is termed as cellulite. Women are more likely to be suffering from cellulite than men. Cellulite is most noticeable on the buttocks and thighs, affecting more than 90 percent of post-adolescent women. There are several factors related to cellulite, the major ones include hormonal factors, diet, genetics, sedentary lifestyle, medications, and certain health conditions.
According to AMA, the market for Cellulite Treatment is expected to register a CAGR of 10.3% during the forecast period to 2026. This growth is primarily driven by Increasing Demand for Minimally Invasive As Well As Non-Invasive Equipment, Rising Demand for Aesthetic Treatments among Men, Increasing Disposable Income, Decreasing Social Taboos Boosting the Acceptance of Esthetic Measures, Technological Advancements and Increasing Disposable Income.

Globally, a noticeable market trend is evident Skin Care Is More Streamlined . The Health Care Technology sector in the North America region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Cynosure, Inc. (United States), Cutera, Inc. (United States), Nestle Merz, Inc. (United States), Mentor Worldwide LLC (United States), Fosun Pharmaceutical Co., Ltd. (China), Allergan plc. (Ireland) and Syneron Medical Ltd. (Israel) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Recently, Hologic's Cynosure division has announced the launch of TempSure Envi, an FDA cleared advanced radiofrequency device that minimizes facial fine lines and wrinkles, tightens skin through soft tissue coagulation, and improves the appearance of cellulite.

Market Drivers
  • Increasing Demand for Minimally Invasive As Well As Non-Invasive Equipment
  • Rising Demand for Aesthetic Treatments among Men
  • Increasing Disposable Income
  • Decreasing Social Taboos Boosting the Acceptance of Esthetic Measures
  • Technological Advancements
  • Increasing Disposable Income

Market Trend
  • Skin Care Is More Streamlined
  • More People Opting Into Professional Skin Care

Restraints
  • Unfavorable Reimbursement Policies
  • Highly Susceptible To Economic Downturn
  • Popular Alternative Herbal Massage Treatment

Opportunities
Emerging Demand from Economies
Challenges
Competitive Pricing and Equipment Costs

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Cellulite Treatment Study Sheds Light on
— The Cellulite Treatment Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Cellulite Treatment industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Cellulite Treatment industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Treatment
  • Energy-based Treatment (Mechanical Suction, Mechanical Suction, and Thermal, Radiofrequency, Ultrasound, Cryolipolysis)
  • Non-Energy-based Treatment (Topical Creams, Oral Treatment)

By End user
  • Hospitals
  • Cosmetic Surgery Centers
  • Dermatology Clinics

By Technique
  • Noninvasive
  • Minimally Invasive

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Demand for Minimally Invasive As Well As Non-Invasive Equipment
      • 3.2.2. Rising Demand for Aesthetic Treatments among Men
      • 3.2.3. Increasing Disposable Income
      • 3.2.4. Decreasing Social Taboos Boosting the Acceptance of Esthetic Measures
      • 3.2.5. Technological Advancements
      • 3.2.6. Increasing Disposable Income
    • 3.3. Market Challenges
      • 3.3.1. Competitive Pricing and Equipment Costs
    • 3.4. Market Trends
      • 3.4.1. Skin Care Is More Streamlined
      • 3.4.2. More People Opting Into Professional Skin Care
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Cellulite Treatment, by Treatment, End user , Technique and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Cellulite Treatment (Value)
      • 5.2.1. Global Cellulite Treatment by: Treatment (Value)
        • 5.2.1.1. Energy-based Treatment (Mechanical Suction, Mechanical Suction, and Thermal, Radiofrequency, Ultrasound, Cryolipolysis)
        • 5.2.1.2. Non-Energy-based Treatment (Topical Creams, Oral Treatment)
      • 5.2.2. Global Cellulite Treatment by: Technique (Value)
        • 5.2.2.1. Noninvasive
        • 5.2.2.2. Minimally Invasive
      • 5.2.3. Global Cellulite Treatment Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Cellulite Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Cynosure, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Cutera, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Nestle Merz, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Mentor Worldwide LLC (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Fosun Pharmaceutical Co., Ltd. (China)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Allergan plc. (Ireland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Syneron Medical Ltd. (Israel)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
  • 7. Global Cellulite Treatment Sale, by Treatment, End user , Technique and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Cellulite Treatment (Value)
      • 7.2.1. Global Cellulite Treatment by: Treatment (Value)
        • 7.2.1.1. Energy-based Treatment (Mechanical Suction, Mechanical Suction, and Thermal, Radiofrequency, Ultrasound, Cryolipolysis)
        • 7.2.1.2. Non-Energy-based Treatment (Topical Creams, Oral Treatment)
      • 7.2.2. Global Cellulite Treatment by: Technique (Value)
        • 7.2.2.1. Noninvasive
        • 7.2.2.2. Minimally Invasive
      • 7.2.3. Global Cellulite Treatment Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Cellulite Treatment: by Treatment(USD Million)
  • Table 2. Cellulite Treatment Energy-based Treatment (Mechanical Suction, Mechanical Suction, and Thermal, Radiofrequency, Ultrasound, Cryolipolysis) , by Region USD Million (2015-2020)
  • Table 3. Cellulite Treatment Non-Energy-based Treatment (Topical Creams, Oral Treatment) , by Region USD Million (2015-2020)
  • Table 4. Cellulite Treatment: by Technique(USD Million)
  • Table 5. Cellulite Treatment Noninvasive , by Region USD Million (2015-2020)
  • Table 6. Cellulite Treatment Minimally Invasive , by Region USD Million (2015-2020)
  • Table 7. South America Cellulite Treatment, by Country USD Million (2015-2020)
  • Table 8. South America Cellulite Treatment, by Treatment USD Million (2015-2020)
  • Table 9. South America Cellulite Treatment, by End user USD Million (2015-2020)
  • Table 10. South America Cellulite Treatment, by Technique USD Million (2015-2020)
  • Table 11. Brazil Cellulite Treatment, by Treatment USD Million (2015-2020)
  • Table 12. Brazil Cellulite Treatment, by End user USD Million (2015-2020)
  • Table 13. Brazil Cellulite Treatment, by Technique USD Million (2015-2020)
  • Table 14. Argentina Cellulite Treatment, by Treatment USD Million (2015-2020)
  • Table 15. Argentina Cellulite Treatment, by End user USD Million (2015-2020)
  • Table 16. Argentina Cellulite Treatment, by Technique USD Million (2015-2020)
  • Table 17. Rest of South America Cellulite Treatment, by Treatment USD Million (2015-2020)
  • Table 18. Rest of South America Cellulite Treatment, by End user USD Million (2015-2020)
  • Table 19. Rest of South America Cellulite Treatment, by Technique USD Million (2015-2020)
  • Table 20. Asia Pacific Cellulite Treatment, by Country USD Million (2015-2020)
  • Table 21. Asia Pacific Cellulite Treatment, by Treatment USD Million (2015-2020)
  • Table 22. Asia Pacific Cellulite Treatment, by End user USD Million (2015-2020)
  • Table 23. Asia Pacific Cellulite Treatment, by Technique USD Million (2015-2020)
  • Table 24. China Cellulite Treatment, by Treatment USD Million (2015-2020)
  • Table 25. China Cellulite Treatment, by End user USD Million (2015-2020)
  • Table 26. China Cellulite Treatment, by Technique USD Million (2015-2020)
  • Table 27. Japan Cellulite Treatment, by Treatment USD Million (2015-2020)
  • Table 28. Japan Cellulite Treatment, by End user USD Million (2015-2020)
  • Table 29. Japan Cellulite Treatment, by Technique USD Million (2015-2020)
  • Table 30. India Cellulite Treatment, by Treatment USD Million (2015-2020)
  • Table 31. India Cellulite Treatment, by End user USD Million (2015-2020)
  • Table 32. India Cellulite Treatment, by Technique USD Million (2015-2020)
  • Table 33. South Korea Cellulite Treatment, by Treatment USD Million (2015-2020)
  • Table 34. South Korea Cellulite Treatment, by End user USD Million (2015-2020)
  • Table 35. South Korea Cellulite Treatment, by Technique USD Million (2015-2020)
  • Table 36. Taiwan Cellulite Treatment, by Treatment USD Million (2015-2020)
  • Table 37. Taiwan Cellulite Treatment, by End user USD Million (2015-2020)
  • Table 38. Taiwan Cellulite Treatment, by Technique USD Million (2015-2020)
  • Table 39. Australia Cellulite Treatment, by Treatment USD Million (2015-2020)
  • Table 40. Australia Cellulite Treatment, by End user USD Million (2015-2020)
  • Table 41. Australia Cellulite Treatment, by Technique USD Million (2015-2020)
  • Table 42. Rest of Asia-Pacific Cellulite Treatment, by Treatment USD Million (2015-2020)
  • Table 43. Rest of Asia-Pacific Cellulite Treatment, by End user USD Million (2015-2020)
  • Table 44. Rest of Asia-Pacific Cellulite Treatment, by Technique USD Million (2015-2020)
  • Table 45. Europe Cellulite Treatment, by Country USD Million (2015-2020)
  • Table 46. Europe Cellulite Treatment, by Treatment USD Million (2015-2020)
  • Table 47. Europe Cellulite Treatment, by End user USD Million (2015-2020)
  • Table 48. Europe Cellulite Treatment, by Technique USD Million (2015-2020)
  • Table 49. Germany Cellulite Treatment, by Treatment USD Million (2015-2020)
  • Table 50. Germany Cellulite Treatment, by End user USD Million (2015-2020)
  • Table 51. Germany Cellulite Treatment, by Technique USD Million (2015-2020)
  • Table 52. France Cellulite Treatment, by Treatment USD Million (2015-2020)
  • Table 53. France Cellulite Treatment, by End user USD Million (2015-2020)
  • Table 54. France Cellulite Treatment, by Technique USD Million (2015-2020)
  • Table 55. Italy Cellulite Treatment, by Treatment USD Million (2015-2020)
  • Table 56. Italy Cellulite Treatment, by End user USD Million (2015-2020)
  • Table 57. Italy Cellulite Treatment, by Technique USD Million (2015-2020)
  • Table 58. United Kingdom Cellulite Treatment, by Treatment USD Million (2015-2020)
  • Table 59. United Kingdom Cellulite Treatment, by End user USD Million (2015-2020)
  • Table 60. United Kingdom Cellulite Treatment, by Technique USD Million (2015-2020)
  • Table 61. Netherlands Cellulite Treatment, by Treatment USD Million (2015-2020)
  • Table 62. Netherlands Cellulite Treatment, by End user USD Million (2015-2020)
  • Table 63. Netherlands Cellulite Treatment, by Technique USD Million (2015-2020)
  • Table 64. Rest of Europe Cellulite Treatment, by Treatment USD Million (2015-2020)
  • Table 65. Rest of Europe Cellulite Treatment, by End user USD Million (2015-2020)
  • Table 66. Rest of Europe Cellulite Treatment, by Technique USD Million (2015-2020)
  • Table 67. MEA Cellulite Treatment, by Country USD Million (2015-2020)
  • Table 68. MEA Cellulite Treatment, by Treatment USD Million (2015-2020)
  • Table 69. MEA Cellulite Treatment, by End user USD Million (2015-2020)
  • Table 70. MEA Cellulite Treatment, by Technique USD Million (2015-2020)
  • Table 71. Middle East Cellulite Treatment, by Treatment USD Million (2015-2020)
  • Table 72. Middle East Cellulite Treatment, by End user USD Million (2015-2020)
  • Table 73. Middle East Cellulite Treatment, by Technique USD Million (2015-2020)
  • Table 74. Africa Cellulite Treatment, by Treatment USD Million (2015-2020)
  • Table 75. Africa Cellulite Treatment, by End user USD Million (2015-2020)
  • Table 76. Africa Cellulite Treatment, by Technique USD Million (2015-2020)
  • Table 77. North America Cellulite Treatment, by Country USD Million (2015-2020)
  • Table 78. North America Cellulite Treatment, by Treatment USD Million (2015-2020)
  • Table 79. North America Cellulite Treatment, by End user USD Million (2015-2020)
  • Table 80. North America Cellulite Treatment, by Technique USD Million (2015-2020)
  • Table 81. United States Cellulite Treatment, by Treatment USD Million (2015-2020)
  • Table 82. United States Cellulite Treatment, by End user USD Million (2015-2020)
  • Table 83. United States Cellulite Treatment, by Technique USD Million (2015-2020)
  • Table 84. Canada Cellulite Treatment, by Treatment USD Million (2015-2020)
  • Table 85. Canada Cellulite Treatment, by End user USD Million (2015-2020)
  • Table 86. Canada Cellulite Treatment, by Technique USD Million (2015-2020)
  • Table 87. Mexico Cellulite Treatment, by Treatment USD Million (2015-2020)
  • Table 88. Mexico Cellulite Treatment, by End user USD Million (2015-2020)
  • Table 89. Mexico Cellulite Treatment, by Technique USD Million (2015-2020)
  • Table 90. Company Basic Information, Sales Area and Its Competitors
  • Table 91. Company Basic Information, Sales Area and Its Competitors
  • Table 92. Company Basic Information, Sales Area and Its Competitors
  • Table 93. Company Basic Information, Sales Area and Its Competitors
  • Table 94. Company Basic Information, Sales Area and Its Competitors
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Cellulite Treatment: by Treatment(USD Million)
  • Table 98. Cellulite Treatment Energy-based Treatment (Mechanical Suction, Mechanical Suction, and Thermal, Radiofrequency, Ultrasound, Cryolipolysis) , by Region USD Million (2021-2026)
  • Table 99. Cellulite Treatment Non-Energy-based Treatment (Topical Creams, Oral Treatment) , by Region USD Million (2021-2026)
  • Table 100. Cellulite Treatment: by Technique(USD Million)
  • Table 101. Cellulite Treatment Noninvasive , by Region USD Million (2021-2026)
  • Table 102. Cellulite Treatment Minimally Invasive , by Region USD Million (2021-2026)
  • Table 103. South America Cellulite Treatment, by Country USD Million (2021-2026)
  • Table 104. South America Cellulite Treatment, by Treatment USD Million (2021-2026)
  • Table 105. South America Cellulite Treatment, by End user USD Million (2021-2026)
  • Table 106. South America Cellulite Treatment, by Technique USD Million (2021-2026)
  • Table 107. Brazil Cellulite Treatment, by Treatment USD Million (2021-2026)
  • Table 108. Brazil Cellulite Treatment, by End user USD Million (2021-2026)
  • Table 109. Brazil Cellulite Treatment, by Technique USD Million (2021-2026)
  • Table 110. Argentina Cellulite Treatment, by Treatment USD Million (2021-2026)
  • Table 111. Argentina Cellulite Treatment, by End user USD Million (2021-2026)
  • Table 112. Argentina Cellulite Treatment, by Technique USD Million (2021-2026)
  • Table 113. Rest of South America Cellulite Treatment, by Treatment USD Million (2021-2026)
  • Table 114. Rest of South America Cellulite Treatment, by End user USD Million (2021-2026)
  • Table 115. Rest of South America Cellulite Treatment, by Technique USD Million (2021-2026)
  • Table 116. Asia Pacific Cellulite Treatment, by Country USD Million (2021-2026)
  • Table 117. Asia Pacific Cellulite Treatment, by Treatment USD Million (2021-2026)
  • Table 118. Asia Pacific Cellulite Treatment, by End user USD Million (2021-2026)
  • Table 119. Asia Pacific Cellulite Treatment, by Technique USD Million (2021-2026)
  • Table 120. China Cellulite Treatment, by Treatment USD Million (2021-2026)
  • Table 121. China Cellulite Treatment, by End user USD Million (2021-2026)
  • Table 122. China Cellulite Treatment, by Technique USD Million (2021-2026)
  • Table 123. Japan Cellulite Treatment, by Treatment USD Million (2021-2026)
  • Table 124. Japan Cellulite Treatment, by End user USD Million (2021-2026)
  • Table 125. Japan Cellulite Treatment, by Technique USD Million (2021-2026)
  • Table 126. India Cellulite Treatment, by Treatment USD Million (2021-2026)
  • Table 127. India Cellulite Treatment, by End user USD Million (2021-2026)
  • Table 128. India Cellulite Treatment, by Technique USD Million (2021-2026)
  • Table 129. South Korea Cellulite Treatment, by Treatment USD Million (2021-2026)
  • Table 130. South Korea Cellulite Treatment, by End user USD Million (2021-2026)
  • Table 131. South Korea Cellulite Treatment, by Technique USD Million (2021-2026)
  • Table 132. Taiwan Cellulite Treatment, by Treatment USD Million (2021-2026)
  • Table 133. Taiwan Cellulite Treatment, by End user USD Million (2021-2026)
  • Table 134. Taiwan Cellulite Treatment, by Technique USD Million (2021-2026)
  • Table 135. Australia Cellulite Treatment, by Treatment USD Million (2021-2026)
  • Table 136. Australia Cellulite Treatment, by End user USD Million (2021-2026)
  • Table 137. Australia Cellulite Treatment, by Technique USD Million (2021-2026)
  • Table 138. Rest of Asia-Pacific Cellulite Treatment, by Treatment USD Million (2021-2026)
  • Table 139. Rest of Asia-Pacific Cellulite Treatment, by End user USD Million (2021-2026)
  • Table 140. Rest of Asia-Pacific Cellulite Treatment, by Technique USD Million (2021-2026)
  • Table 141. Europe Cellulite Treatment, by Country USD Million (2021-2026)
  • Table 142. Europe Cellulite Treatment, by Treatment USD Million (2021-2026)
  • Table 143. Europe Cellulite Treatment, by End user USD Million (2021-2026)
  • Table 144. Europe Cellulite Treatment, by Technique USD Million (2021-2026)
  • Table 145. Germany Cellulite Treatment, by Treatment USD Million (2021-2026)
  • Table 146. Germany Cellulite Treatment, by End user USD Million (2021-2026)
  • Table 147. Germany Cellulite Treatment, by Technique USD Million (2021-2026)
  • Table 148. France Cellulite Treatment, by Treatment USD Million (2021-2026)
  • Table 149. France Cellulite Treatment, by End user USD Million (2021-2026)
  • Table 150. France Cellulite Treatment, by Technique USD Million (2021-2026)
  • Table 151. Italy Cellulite Treatment, by Treatment USD Million (2021-2026)
  • Table 152. Italy Cellulite Treatment, by End user USD Million (2021-2026)
  • Table 153. Italy Cellulite Treatment, by Technique USD Million (2021-2026)
  • Table 154. United Kingdom Cellulite Treatment, by Treatment USD Million (2021-2026)
  • Table 155. United Kingdom Cellulite Treatment, by End user USD Million (2021-2026)
  • Table 156. United Kingdom Cellulite Treatment, by Technique USD Million (2021-2026)
  • Table 157. Netherlands Cellulite Treatment, by Treatment USD Million (2021-2026)
  • Table 158. Netherlands Cellulite Treatment, by End user USD Million (2021-2026)
  • Table 159. Netherlands Cellulite Treatment, by Technique USD Million (2021-2026)
  • Table 160. Rest of Europe Cellulite Treatment, by Treatment USD Million (2021-2026)
  • Table 161. Rest of Europe Cellulite Treatment, by End user USD Million (2021-2026)
  • Table 162. Rest of Europe Cellulite Treatment, by Technique USD Million (2021-2026)
  • Table 163. MEA Cellulite Treatment, by Country USD Million (2021-2026)
  • Table 164. MEA Cellulite Treatment, by Treatment USD Million (2021-2026)
  • Table 165. MEA Cellulite Treatment, by End user USD Million (2021-2026)
  • Table 166. MEA Cellulite Treatment, by Technique USD Million (2021-2026)
  • Table 167. Middle East Cellulite Treatment, by Treatment USD Million (2021-2026)
  • Table 168. Middle East Cellulite Treatment, by End user USD Million (2021-2026)
  • Table 169. Middle East Cellulite Treatment, by Technique USD Million (2021-2026)
  • Table 170. Africa Cellulite Treatment, by Treatment USD Million (2021-2026)
  • Table 171. Africa Cellulite Treatment, by End user USD Million (2021-2026)
  • Table 172. Africa Cellulite Treatment, by Technique USD Million (2021-2026)
  • Table 173. North America Cellulite Treatment, by Country USD Million (2021-2026)
  • Table 174. North America Cellulite Treatment, by Treatment USD Million (2021-2026)
  • Table 175. North America Cellulite Treatment, by End user USD Million (2021-2026)
  • Table 176. North America Cellulite Treatment, by Technique USD Million (2021-2026)
  • Table 177. United States Cellulite Treatment, by Treatment USD Million (2021-2026)
  • Table 178. United States Cellulite Treatment, by End user USD Million (2021-2026)
  • Table 179. United States Cellulite Treatment, by Technique USD Million (2021-2026)
  • Table 180. Canada Cellulite Treatment, by Treatment USD Million (2021-2026)
  • Table 181. Canada Cellulite Treatment, by End user USD Million (2021-2026)
  • Table 182. Canada Cellulite Treatment, by Technique USD Million (2021-2026)
  • Table 183. Mexico Cellulite Treatment, by Treatment USD Million (2021-2026)
  • Table 184. Mexico Cellulite Treatment, by End user USD Million (2021-2026)
  • Table 185. Mexico Cellulite Treatment, by Technique USD Million (2021-2026)
  • Table 186. Research Programs/Design for This Report
  • Table 187. Key Data Information from Secondary Sources
  • Table 188. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Cellulite Treatment: by Treatment USD Million (2015-2020)
  • Figure 5. Global Cellulite Treatment: by Technique USD Million (2015-2020)
  • Figure 6. South America Cellulite Treatment Share (%), by Country
  • Figure 7. Asia Pacific Cellulite Treatment Share (%), by Country
  • Figure 8. Europe Cellulite Treatment Share (%), by Country
  • Figure 9. MEA Cellulite Treatment Share (%), by Country
  • Figure 10. North America Cellulite Treatment Share (%), by Country
  • Figure 11. Global Cellulite Treatment share by Players 2020 (%)
  • Figure 12. Global Cellulite Treatment share by Players (Top 3) 2020(%)
  • Figure 13. BCG Matrix for key Companies
  • Figure 14. Cynosure, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 15. Cynosure, Inc. (United States) Revenue: by Geography 2020
  • Figure 16. Cutera, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 17. Cutera, Inc. (United States) Revenue: by Geography 2020
  • Figure 18. Nestle Merz, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Nestle Merz, Inc. (United States) Revenue: by Geography 2020
  • Figure 20. Mentor Worldwide LLC (United States) Revenue, Net Income and Gross profit
  • Figure 21. Mentor Worldwide LLC (United States) Revenue: by Geography 2020
  • Figure 22. Fosun Pharmaceutical Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 23. Fosun Pharmaceutical Co., Ltd. (China) Revenue: by Geography 2020
  • Figure 24. Allergan plc. (Ireland) Revenue, Net Income and Gross profit
  • Figure 25. Allergan plc. (Ireland) Revenue: by Geography 2020
  • Figure 26. Syneron Medical Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 27. Syneron Medical Ltd. (Israel) Revenue: by Geography 2020
  • Figure 28. Global Cellulite Treatment: by Treatment USD Million (2021-2026)
  • Figure 29. Global Cellulite Treatment: by Technique USD Million (2021-2026)
  • Figure 30. South America Cellulite Treatment Share (%), by Country
  • Figure 31. Asia Pacific Cellulite Treatment Share (%), by Country
  • Figure 32. Europe Cellulite Treatment Share (%), by Country
  • Figure 33. MEA Cellulite Treatment Share (%), by Country
  • Figure 34. North America Cellulite Treatment Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Cynosure, Inc. (United States)
  • Cutera, Inc. (United States)
  • Nestle Merz, Inc. (United States)
  • Mentor Worldwide LLC (United States)
  • Fosun Pharmaceutical Co., Ltd. (China)
  • Allergan plc. (Ireland)
  • Syneron Medical Ltd. (Israel)
Select User Access Type

Key Highlights of Report


Nov 2021 226 Pages 84 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Cellulite Treatment Market Quantitative research analysis
Global Cellulite Treatment Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Cellulite Treatment market is expected to see a CAGR of 10.3% during projected year 2020 to 2026.
Top performing companies in the Global Cellulite Treatment market are Cynosure, Inc. (United States), Cutera, Inc. (United States), Nestle Merz, Inc. (United States), Mentor Worldwide LLC (United States), Fosun Pharmaceutical Co., Ltd. (China), Allergan plc. (Ireland) and Syneron Medical Ltd. (Israel), to name a few.
North America is dominating the Cellulite Treatment Market.

Know More About Global Cellulite Treatment Market Report?

Have a Query? Click Here

Other Related Reports

Healthcare 3D Printing Comprehensive Study by Type (Syringe Based, Magnetic Levitation, Laser Based, Inkjet Based), Application (Biosensors, Medical {Pharmaceutical, Prosthetics and Implants, Tissue ...
$ 3750
Immunoassay Comprehensive Study by Type (Reagents and Kits, Analyzers, Software and Services), Application (Infectious Disease, Endocrinology, Oncology, Cardiology, Hematology and Blood Screening, Au...
$ 3750
Health Care Information Systems Comprehensive Study by Type (Electronic Health Record, Electronic Medical record, Clinical Decision Support, E- prescribing, Personal Health Record, Patient engagement...
$ 3750
Sterilization Technologies Comprehensive Study by Type (Chemical & Gas Sterilization (Ethylene Oxide, Formaldehyde, Others), Filtration Sterilization (Liquid, Air & Gas), Ionizing Radiation Steriliza...
$ 3750
Micro-Ultrasound Systems Comprehensive Study by Type (Non-invasive imaging, Invasive imaging), Application (Cancer Research or Tumor Volume, Lesion Detection, Drug Efficacy), End User Industries (Hos...
$ 3650
Teleradiology Comprehensive Study by Type (X-ray, Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Ultrasound, Nuclear Radiology), Application (On-Call Coverage, Primary Interpretations, I...
$ 3650